140 related articles for article (PubMed ID: 11866205)
21. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
22. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
Lindahl B; Alm P
Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
[TBL] [Abstract][Full Text] [Related]
23. [Flow cytometric DNA content analysis in thyroid carcinoma].
Zuo LF
Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):106-9. PubMed ID: 1879287
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric DNA analysis of normal and pathologic parathyroid glands.
Harlow S; Roth SI; Bauer K; Marshall RB
Mod Pathol; 1991 May; 4(3):310-5. PubMed ID: 2068056
[TBL] [Abstract][Full Text] [Related]
25. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
26. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi.
Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H
Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609
[TBL] [Abstract][Full Text] [Related]
27. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
29. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
30. Quantitative study of the precancerous and malignant lesions in colorectal adenomas.
Ranaldi R; Bearzi I; Santinelli A; Mannello B; Mariuzzi GM
Pathol Res Pract; 1992 Jun; 188(4-5):561-4. PubMed ID: 1409089
[TBL] [Abstract][Full Text] [Related]
31. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability.
Jovanovic AS; Boynton KA; Mutter GL
Cancer Res; 1996 Apr; 56(8):1917-21. PubMed ID: 8620514
[TBL] [Abstract][Full Text] [Related]
32. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
Xue F; Jiao S; Zhao F
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
[TBL] [Abstract][Full Text] [Related]
33. Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.
Crissman JD; Visscher DW; Kubus J
Arch Pathol Lab Med; 1990 Dec; 114(12):1249-53. PubMed ID: 2174672
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometry in invasive endometrial carcinoma. Correlations between DNA content S-phase rate and clinical parameters.
Stendahl U; Wagenius G; Strang P; Tribukait B
In Vivo; 1988; 2(2):123-7. PubMed ID: 2979827
[TBL] [Abstract][Full Text] [Related]
35. [Comparative evaluation of gastro-intestinal tract tumors on the basis of data from determination of DNA content using flow cytometry].
Chistiakova OV; Zubrikhina GN; Rottenberg VI; Nechpaĭ AM
Arkh Patol; 1991; 53(3):49-53. PubMed ID: 1649585
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma.
Pfisterer J; Kommoss F; Sauerbrei W; Rendl I; Kiechle M; Kleine W; Pfleiderer A
Gynecol Oncol; 1995 Aug; 58(2):149-56. PubMed ID: 7622098
[TBL] [Abstract][Full Text] [Related]
37. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric evaluation of early invasive cervical cancer.
Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
[TBL] [Abstract][Full Text] [Related]
39. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
40. DNA image cytometry in the differential diagnosis of endometrial hyperplasia and adenocarcinoma.
Biesterfeld S; Leitloff M; Rath W; Schröder W
Anal Quant Cytol Histol; 2001 Apr; 23(2):123-8. PubMed ID: 11332078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]